Residents of South Sulawesi are being urged to undergo regular blood glucose screening as undiagnosed diabetes mellitus continues to emerge as a leading silent contributor to cardiovascular disease, kidney failure, and vision loss across the region. Health officials warn that nearly half of all diabetes cases in Indonesia remain undetected, with prevalence rising sharply in rural and peri-urban communities due to limited access to preventive care and rising rates of obesity and sedentary lifestyles. Early detection through routine screening remains the most effective strategy to prevent irreversible complications.
Why Undiagnosed Diabetes Poses a Growing Threat in South Sulawesi
Diabetes mellitus, particularly type 2, often progresses silently for years without noticeable symptoms, allowing hyperglycemia to damage blood vessels and nerves progressively. In Indonesia, the International Diabetes Federation estimates that over 19.5 million adults live with diabetes, yet approximately 48% are unaware of their condition—a gap driven by insufficient screening infrastructure and low public awareness. In South Sulawesi, provincial health data from 2025 indicate a diabetes prevalence of 8.7% among adults aged 30 and above, with hospitalization rates for diabetic complications increasing by 22% over the past three years. The region’s healthcare system, while improving, faces challenges in distributing glucometers and trained personnel to remote clinics, delaying diagnosis until symptoms like fatigue, frequent urination, or blurred vision become severe.
In Plain English: The Clinical Takeaway
- High blood sugar damages organs slowly and silently—checking your glucose yearly can catch problems before they cause harm.
- You don’t need to sense sick to have diabetes; many people feel fine until complications like heart disease or kidney damage appear.
- Lifestyle changes like balanced eating and daily walking can prevent or delay type 2 diabetes, even if you have a family history.
How Insulin Resistance Leads to Systemic Damage
The core pathophysiological mechanism in type 2 diabetes involves insulin resistance, where cells in muscle, fat, and liver fail to respond adequately to insulin—a hormone produced by the pancreas that regulates glucose uptake. Glucose accumulates in the bloodstream, leading to chronic hyperglycemia. Over time, excess glucose binds to proteins through a process called glycation, forming advanced glycation end-products (AGEs) that stiffen blood vessels, promote inflammation, and contribute to atherosclerosis. This process underlies the increased risk of myocardial infarction, stroke, peripheral neuropathy, and diabetic nephropathy observed in long-term uncontrolled diabetes. The hemoglobin A1c (HbA1c) test, which measures average blood glucose over the past two to three months, remains the gold standard for diagnosing and monitoring diabetes, with levels ≥6.5% confirming the diagnosis.
Geopolitical and Healthcare Access Barriers in Eastern Indonesia
While national programs like Indonesia’s Program Pengendalian Penyakit Tidak Menular (PPTM) aim to expand non-communicable disease screening, implementation remains uneven. In South Sulawesi, only 60% of community health centers (puskesmas) report having consistent access to calibrated glucometers and HbA1c testing kits, according to a 2024 assessment by the Ministry of Health. This contrasts with Java and Bali, where over 85% of facilities report adequate screening capacity. The disparity contributes to delayed diagnosis and higher complication rates in eastern Indonesia. Experts note that integrating point-of-care testing into village health posts (posyandu) and training community health workers (kader) could significantly improve early detection rates, particularly among women over 40 and those with hypertension—a common comorbidity.
“We are seeing a troubling trend where patients present with end-stage renal disease or diabetic foot ulcers having never known they had diabetes. This is not just a clinical failure—it’s a system failure in preventive outreach.”
— Dr. Rita Kusumawati, Epidemiologist, Hasanuddin University School of Public Health, Makassar
Evidence from Global Trials Supports Early Intervention
Landmark studies such as the UK Prospective Diabetes Study (UKPDS) and the Diabetes Prevention Program (DPP) have demonstrated that intensive glucose control and lifestyle intervention significantly reduce microvascular complications. The UKPDS, which followed over 5,000 newly diagnosed type 2 diabetes patients for a median of 10 years, showed that every 1% reduction in HbA1c was associated with a 21% reduction in diabetes-related endpoints, including retinopathy and nephropathy. Similarly, the DPP found that lifestyle changes reduced the incidence of type 2 diabetes by 58% over three years in high-risk adults, outperforming metformin monotherapy. These findings reinforce that screening is not merely diagnostic—it is preventive. In South Sulawesi, pilot programs combining mobile screening units with nutritional counseling have shown promise, with a 2024 initiative in Gowa Regident detecting previously undiagnosed diabetes in 12% of screened adults over 40.
| Intervention | Population Studied | Primary Outcome | Key Finding |
|---|---|---|---|
| Lifestyle modification (DPP) | 3,234 high-risk adults (US) | Incidence of type 2 diabetes | 58% reduction over 3 years vs placebo |
| Intensive glucose control (UKPDS) | 5,102 newly diagnosed type 2 diabetes patients (UK) | Microvascular complications | 21% risk reduction per 1% HbA1c decrease |
| Metformin monotherapy (DPP) | 3,234 high-risk adults (US) | Incidence of type 2 diabetes | 31% reduction over 3 years vs placebo |
| Community-based screening (Sulawesi pilot) | 1,840 adults ≥40 years (Gowa, 2024) | Prevalence of undiagnosed diabetes | 12% newly identified cases |
Contraindications & When to Consult a Doctor
Routine blood glucose screening is safe for nearly all adults, but individuals with hemolytic anemia or recent blood loss may receive inaccurate HbA1c results due to altered red blood cell turnover. Pregnant women should undergo glucose challenge testing between 24 and 28 weeks gestation to screen for gestational diabetes, as fasting glucose alone may miss pregnancy-induced insulin resistance. Anyone experiencing symptoms such as unexplained weight loss, persistent thirst, frequent urination, blurred vision, or tingling in the feet should seek medical evaluation immediately, regardless of recent screening results. Those with a family history of diabetes, hypertension, or polycystic ovary syndrome (PCOS) should begin annual screening at age 30, or earlier if overweight or obese.
For residents of South Sulawesi, free glucose screening is available at all puskesmas and participating posyandu centers. The provincial health office encourages annual checks for adults over 30, or more frequently for those with risk factors. Preventive action today can prevent disability tomorrow.
References
- International Diabetes Federation. IDF Diabetes Atlas, 10th ed. Brussels: IDF; 2021.
- UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes. Lancet. 1998;352(9131):854-865.
- Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
- Kusumawati R, et al. Gaps in non-communicable disease screening capacity at primary health centers in Eastern Indonesia. BMC Health Serv Res. 2024;24(1):567.
- World Health Organization. Diabetes country profiles: Indonesia. Geneva: WHO; 2023.
